CY1122198T1 - Ιατρικο προϊον και θεραπεια - Google Patents

Ιατρικο προϊον και θεραπεια

Info

Publication number
CY1122198T1
CY1122198T1 CY20191100377T CY191100377T CY1122198T1 CY 1122198 T1 CY1122198 T1 CY 1122198T1 CY 20191100377 T CY20191100377 T CY 20191100377T CY 191100377 T CY191100377 T CY 191100377T CY 1122198 T1 CY1122198 T1 CY 1122198T1
Authority
CY
Cyprus
Prior art keywords
therapy
medical product
paracetamol
ibuprofen
medicament
Prior art date
Application number
CY20191100377T
Other languages
English (en)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1122198(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Limited filed Critical Aft Pharmaceuticals Limited
Publication of CY1122198T1 publication Critical patent/CY1122198T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η χρήση παρακεταμόλης και ιβουπροφαίνης στην παρασκευή φαρμάκου για θεραπεία οστεοαρθρίτιδας ή ρευματοειδούς αρθρίτιδας, όπου το φάρμακο περιλαμβάνει σύνθεση συνδυασμού που έχει περίπου 125 χλστγρ. έως περίπου 150 χλστγρ. ιβουπροφαίνη και περίπου 475 χλστγρ. έως περίπου 500 χλστγρ. παρακεταμόλη.
CY20191100377T 2008-10-14 2019-04-05 Ιατρικο προϊον και θεραπεια CY1122198T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
PCT/NZ2009/000220 WO2010044681A1 (en) 2008-10-14 2009-10-12 A medicinal product and treatment

Publications (1)

Publication Number Publication Date
CY1122198T1 true CY1122198T1 (el) 2020-11-25

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100377T CY1122198T1 (el) 2008-10-14 2019-04-05 Ιατρικο προϊον και θεραπεια

Country Status (29)

Country Link
US (1) US20110166234A1 (el)
EP (1) EP2341900B1 (el)
JP (1) JP2012505830A (el)
KR (1) KR20110112279A (el)
CN (1) CN102215835A (el)
AU (1) AU2009304002B9 (el)
BR (1) BRPI0914086A2 (el)
CA (1) CA2735834C (el)
CH (1) CH702339B1 (el)
CL (1) CL2011000678A1 (el)
CO (1) CO6341553A2 (el)
CY (1) CY1122198T1 (el)
DK (1) DK2341900T3 (el)
ES (1) ES2725151T3 (el)
GB (1) GB2476418B (el)
HR (1) HRP20190891T1 (el)
HU (1) HUE043063T2 (el)
LT (1) LT2341900T (el)
MA (1) MA32635B1 (el)
MX (1) MX340662B (el)
MY (1) MY153932A (el)
NZ (1) NZ591496A (el)
PL (1) PL2341900T3 (el)
PT (1) PT2341900T (el)
RU (1) RU2487707C2 (el)
SI (1) SI2341900T1 (el)
TR (2) TR201102810T2 (el)
WO (1) WO2010044681A1 (el)
ZA (1) ZA201101752B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007101686A (ru) 2004-07-07 2008-08-20 АФТ Фармасьютикалз Лимитед (NZ) Комбинированная композиция
EP2635269B1 (en) * 2010-11-04 2019-05-22 AFT Pharmaceuticals Limited A combination composition
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
EP3651721A4 (en) 2017-07-10 2021-04-21 Gel Cap Technologies, LLC DUAL RELEASE CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR THEIR MANUFACTURE
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
RU2007101686A (ru) 2004-07-07 2008-08-20 АФТ Фармасьютикалз Лимитед (NZ) Комбинированная композиция
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
CA2735834A1 (en) 2010-04-22
CL2011000678A1 (es) 2011-09-23
RU2011111792A (ru) 2012-11-27
CO6341553A2 (es) 2011-11-21
HRP20190891T1 (hr) 2019-07-12
RU2487707C2 (ru) 2013-07-20
US20110166234A1 (en) 2011-07-07
PL2341900T3 (pl) 2019-08-30
AU2009304002B2 (en) 2013-04-18
MX2011003928A (es) 2011-08-12
TR201906742T4 (tr) 2019-05-21
GB2476418B (en) 2013-04-24
WO2010044681A1 (en) 2010-04-22
DK2341900T3 (da) 2019-05-20
EP2341900A4 (en) 2012-02-29
MY153932A (en) 2015-04-15
ZA201101752B (en) 2012-02-29
MA32635B1 (fr) 2011-09-01
AU2009304002A1 (en) 2010-04-22
LT2341900T (lt) 2019-04-10
CH702339B1 (de) 2016-06-15
NZ591496A (en) 2012-12-21
CN102215835A (zh) 2011-10-12
MX340662B (es) 2016-07-20
ES2725151T3 (es) 2019-09-19
SI2341900T1 (sl) 2019-06-28
EP2341900B1 (en) 2019-02-20
CA2735834C (en) 2017-05-16
PT2341900T (pt) 2019-05-14
BRPI0914086A2 (pt) 2020-01-21
GB201105249D0 (en) 2011-05-11
TR201102810T2 (tr) 2011-05-23
HUE043063T2 (hu) 2019-07-29
EP2341900A1 (en) 2011-07-13
GB2476418A (en) 2011-06-22
KR20110112279A (ko) 2011-10-12
AU2009304002B9 (en) 2014-06-26
JP2012505830A (ja) 2012-03-08

Similar Documents

Publication Publication Date Title
CY1122198T1 (el) Ιατρικο προϊον και θεραπεια
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
CY1120022T1 (el) Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας
CY1120389T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει εναν glp-1-αγωνιστη, μια ινσουλινη και μεθειονινη
CY1116727T1 (el) Θεραπεια πολλαπλης σκληρυνσης me laquinimod
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
CY1117326T1 (el) Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson
CY1116494T1 (el) Θεραπευτικη αγωγη θρομβοεμβολικων διαταραχων με ριβαροξαβανη
CY1123398T1 (el) Συνθεση συνδυασμου
CY1113136T1 (el) Αντιμετωπιση των διαταραχων των χονδρων με ton fgf-18
CY1118179T1 (el) Φαρμακευτικη συνθεση
CY1113963T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
CY1114400T1 (el) Θεραπευτικες εφαρμογες των παραγωγων κιναζολινεδιονης
RS54014B1 (en) COMBINATION FOR TREATMENT OF MUCOSITIS CAUSED BY RADIATION OR CHEMOTHERAPY
CY1118036T1 (el) Βελτιστοποιημενη συνθεση καθαρων μη-πολυμορφικων, κρυσταλλικων χολικων οξεων με καθορισμενο μεγεθος σωματιδιων
MY149863A (en) Delayed-release glucocorticoid treatment of rheumatoid disease
CY1116914T1 (el) ΧΡΗΣΗ ΒΕΝΖΥΔΑΜΙΝΗΣ ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΑΣΘΕΝΕΙΩΝ ΕΞΑΡΤΩΜΕΝΩΝ ΑΠΟ ΤΗΝ p40
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
CY1116502T1 (el) Γονιδιακη εκφραση και πονος